Thermo Fisher Scientific Releases New Biopharmaceutical Characterization Technology

June 7, 2016
BioPharm International Editors

The company showcased new technologies at ASMS for biopharmaceutical characterization.

Thermo Fisher Scientific released new technologies for biopharmaceutical characterization at the American Society for Mass Spectrometry Conference (ASMS) in Texas, the company said in a press announcement. One of the featured products included Thermo Scientific’s Q Exactive BioPharma MS/MS Hybrid Quadropole-Orbitrap mass spectrometer. The spectrometer uses high-resolution, accurate-mass (HRAM) capabilities of the Orbitrap mass analyzer to enable key workflows for protein characterization in a single instrument. Combined with recommended sample preparation and analysis methods using Thermo Scientific reagents, columns, ultra high-pressure liquid chromatography (UHPLC) and data processing technologies, the Q Exactive BioPharma system provides a comprehensive solution for biopharmaceutical characterization. The company also showcased its new workflow driven software and cloud solutions to allow users to analyze insights in several applications, including proteomics, metabolomics, food safety, and biopharmaceutical characterization.

Source: Thermo Fisher Scientific